Financial results for Q2 ended June 30, 2025
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 14720667
- Dividend
- 5
- Unconsolidated Pat
- 2068811
- Unconsolidated Quarter Eps
- 6.50
- Ex Date
- 2025-09-08
- Unconsolidated Cumulative Eps
- 13.17
- Book Closure Dates
- 2025-09-09 - 2025-09-11